Ultragenyx projects $640M-$670M in 2025 revenue growth driven by product launches
Discover how Ultragenyx achieved 29% revenue growth in 2024, set 2025 guidance at $640M-$670M, and advanced clinical progress toward profitability by 2027.
Exploring 185 years of plant collections to enhance future biodiversity studies
To plan for the future, it's sometimes necessary to look to the past. To improve natural history collection and analysis in ...
Novo Nordisk: Dips Like These Come Once Every Few Years
Novo Nordisk shares dropped due to CagriSema trial results but have long-term upside. Learn why NVO stock is a Strong Buy ...